2518542 Alberta Ltd agreed to acquire Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp. (TSXV:KHRN) for CAD 3 million on July 28, 2023. Here the purchase price CAD 3 million is subject to customary closing and post-closing adjustments. The purchase price will be satisfied by way of a paid cash deposit in the amount of CAD 0.5 million and a three year, non-interest bearing vendor takeback promissory note. In addition, pursuant to the definitive agreement, the 2518542 Alberta Ltd has advanced an aggregate amount of CAD 1.45 million with regards to subsidiary growth capital which will be disbursed to all these subsidiaries contemplated by a mutually agreed interim operating plan for the subject subsidiaries unless otherwise agreed to by the 2518542 Alberta Ltd. Based on the terms and agreements Pharmadrug Regulatory Approval is not obtained by November 30, 2023, the purchase price shall be reduced in accordance with the terms and conditions of the definitive agreement. Closing of the Transaction is subject to approval from the TSX Venture Exchange, German Foreign Trade and Payments Act and the German Foreign Trade and Payments Regulation and other customary closing conditions. The closing of the Transaction is expected to occur in two stages, whereby the Khiron Life Sciences Corp and the 2518542 Alberta Ltd will complete the sale and purchase of all of the issued and outstanding shares of Khiron Europe, Zerenia UK, Khiron Spain and Khiron UK on the first closing date we can treat as first stage and the sale and purchase of all of the issued and outstanding shares of Pharmadrug on the second closing date provided that the Pharmadrug Regulatory Approval is obtained is second stage. As of November 16, 2023, TSX Venture Exchange, German Foreign Trade and Payments Act and the German Foreign Trade and Payments Regulation approved the transaction of Pharmadrug Production GmbH. The Pharmadrug Production GmbH transaction is expected to occur on or about November 17, 2023.

2518542 Alberta Ltd completed the acquisition of Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp. (TSXV:KHRN) on November 17, 2023.